These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Phosphorylation of the liver X receptors. Chen M; Bradley MN; Beaven SW; Tontonoz P FEBS Lett; 2006 Sep; 580(20):4835-41. PubMed ID: 16904112 [TBL] [Abstract][Full Text] [Related]
44. Identification of human low-density lipoprotein receptor as a novel target gene regulated by liver X receptor alpha. Ishimoto K; Tachibana K; Sumitomo M; Omote S; Hanano I; Yamasaki D; Watanabe Y; Tanaka T; Hamakubo T; Sakai J; Kodama T; Doi T FEBS Lett; 2006 Sep; 580(20):4929-33. PubMed ID: 16920108 [TBL] [Abstract][Full Text] [Related]
45. Transcriptional and posttranscriptional control of cholesterol homeostasis by liver X receptors. Tontonoz P Cold Spring Harb Symp Quant Biol; 2011; 76():129-37. PubMed ID: 21859674 [TBL] [Abstract][Full Text] [Related]
46. A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor up-regulates sterol transporters and cholesterol efflux in macrophages through a peroxisome proliferator-activated receptor gamma-dependent pathway. Avallone R; Demers A; Rodrigue-Way A; Bujold K; Harb D; Anghel S; Wahli W; Marleau S; Ong H; Tremblay A Mol Endocrinol; 2006 Dec; 20(12):3165-78. PubMed ID: 16959872 [TBL] [Abstract][Full Text] [Related]
47. Liver X receptor activation potentiates the lipopolysaccharide response in human macrophages. Fontaine C; Rigamonti E; Nohara A; Gervois P; Teissier E; Fruchart JC; Staels B; Chinetti-Gbaguidi G Circ Res; 2007 Jul; 101(1):40-9. PubMed ID: 17540978 [TBL] [Abstract][Full Text] [Related]
48. PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway. Ruan XZ; Moorhead JF; Fernando R; Wheeler DC; Powis SH; Varghese Z J Am Soc Nephrol; 2003 Mar; 14(3):593-600. PubMed ID: 12595494 [TBL] [Abstract][Full Text] [Related]
49. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting. Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483 [TBL] [Abstract][Full Text] [Related]
50. Cholesterol-receptor-mediated genomics in health and disease. Kaul D Trends Mol Med; 2003 Oct; 9(10):442-9. PubMed ID: 14557057 [TBL] [Abstract][Full Text] [Related]
52. What are the characteristics of vitamin D metabolism in opioid dependence? An exploratory longitudinal study in Australian primary care. Reece AS; Hulse GK BMJ Open; 2018 Jan; 8(1):e016806. PubMed ID: 29331964 [TBL] [Abstract][Full Text] [Related]
53. Classical conditioning of the rabbit's nictitating membrane response is a function of the duration of dietary cholesterol. Schreurs BG; Smith-Bell CA; Darwish DS; Stankovic G; Sparks DL Nutr Neurosci; 2007; 10(3-4):159-68. PubMed ID: 18019398 [TBL] [Abstract][Full Text] [Related]